A device being commercialized by NeuroVision Imaging has been shown in a 40-patient study to have the ability to accurately detect Alzheimer's disease. Designed to identify beta-amyloid plaque buildup in the retina, the device eliminates the need to collect samples from the nervous system and could be used to detect Alzheimer's as early as two decades prior to a clinical diagnosis, according to researchers.

Full Story:

Related Summaries